Nektar Therapeutics: Form 8-K, filed Feb 10, 2026
Filed with the SEC on Feb 10, 2026 and accepted by EDGAR at Feb 10, 2026, 21:21 ET.
Items reported
- Item 7.01 Regulation FD disclosure
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001193125-26-044751. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.